Grantham, Mayo, Van Otterloo & Co (GMO)’s Itron ITRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$45.2M Buy
522,662
+75,522
+17% +$6.45M 0.1% 81
2026
Q1
$40.1M Buy
447,140
+226,019
+102% +$21.7M 0.1% 89
2025
Q4
$20.5M Buy
221,121
+83,021
+60% +$9.04M 0.05% 171
2025
Q3
$17.2M Buy
138,100
+62,100
+82% +$7.9M 0.05% 188
2025
Q2
$10M Buy
+76,000
New +$8.6M 0.03% 231
2020
Q2
Sell
-54,233
Closed -$3.03M 794
2020
Q1
$3.03M Buy
54,233
+50,933
+1,543% +$3.87M 0.03% 328
2019
Q4
$277K Buy
+3,300
New +$260K ﹤0.01% 634

Other funds holding ITRI

Grantham, Mayo, Van Otterloo & Co (GMO)'s ITRI Position: Q2 2026 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) increased its Itron (ITRI) stake by 17% in Q2 2026, buying an estimated $6.45M and bringing the position to 522,662 shares worth $45.2M. The position accounts for 0.1% of the portfolio, ranked #81.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in ITRI in Q4 2019 and has held it in 7 quarters since. 413 funds tracked by Wall St. Rank hold ITRI as of Q2 2026.

  • Grantham, Mayo, Van Otterloo & Co (GMO) held 522,662 shares of Itron worth $45.2M as of Q2 2026.
  • Grantham, Mayo, Van Otterloo & Co (GMO) bought 75,522 Itron shares in Q2 2026, an estimated $6.45M.
  • Itron made up 0.1% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q2 2026, its #81 holding.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Itron in Q4 2019 and has held it in 7 quarters since.
  • 413 funds tracked by Wall St. Rank held Itron as of Q2 2026.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2026, filed 13 Aug 2026.